Biocept reported $-2707000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Becton, Dickinson and BDX:US $ 535M 117M
Biocept BIOC:US $ -2.71M 0.07M
Celldex Therapeutics CLDX:US $ -36.4M 13.14M
Cerulean Pharma CERU:US $ -8400450 1.14M
Cytori Therapeutics CYTX:US $ -5120000 1.19M
General Electric GE:US $ 851M 1567M
Illumina ILMN:US $ -579000000 763M
Quest Diagnostics DGX:US $ 388M 125M
Thermo Fisher Scientific TMO:US $ 2001M 820M